CN103989185A - Deep sea fish oil soft capsule containing coenzyme Q - Google Patents
Deep sea fish oil soft capsule containing coenzyme Q Download PDFInfo
- Publication number
- CN103989185A CN103989185A CN201410260111.6A CN201410260111A CN103989185A CN 103989185 A CN103989185 A CN 103989185A CN 201410260111 A CN201410260111 A CN 201410260111A CN 103989185 A CN103989185 A CN 103989185A
- Authority
- CN
- China
- Prior art keywords
- fish oil
- sea fish
- deep sea
- soft capsule
- coenzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000021323 fish oil Nutrition 0.000 title claims abstract description 21
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title claims abstract description 20
- 239000007901 soft capsule Substances 0.000 title claims abstract description 13
- 235000017471 coenzyme Q10 Nutrition 0.000 title abstract 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 229940046009 vitamin E Drugs 0.000 claims abstract description 7
- 239000011709 vitamin E Substances 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims description 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 7
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 4
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract description 4
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 4
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 210000004413 cardiac myocyte Anatomy 0.000 abstract description 2
- 230000004217 heart function Effects 0.000 abstract description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 6
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract 3
- 229940110767 coenzyme Q10 Drugs 0.000 abstract 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 3
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 3
- 239000004615 ingredient Substances 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 206010061216 Infarction Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007574 infarction Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/20—Fish extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a deep sea fish oil soft capsule containing a coenzyme Q. The deep sea fish oil soft capsule comprises main effective ingredients of deep sea fish oil [containing EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid)], a coenzyme Q10 and a vitamin E, and main excipients of water, glycerinum and edible animal gelatin. The deep sea fish oil soft capsule has the beneficial effects that omega-3 highly unsaturated fatty acids (EPA, DHA) and the fat-soluble coenzyme Q10 are effectively combined, ingredients are further in a synergistic effect, and cardiovascular and cerebrovascular diseases can be prevented. Meanwhile, the coenzyme Q10 provides more energy for cardiac muscle cells, so that the heart function is enhanced, and the symptoms of the cardiovascular and cerebrovascular diseases can be rapidly and effectively improved.
Description
(1) technical field
The present invention relates to a kind of fish oil soft capsule, especially a kind of deep-sea fish oil soft capsules that contains Co-Q10, belongs to health food technology field.
(2) background technology
At present, along with improving constantly of living standard, people constantly increase the intake of higher fatty acid meat product, incident is the continuous rising of fat content in blood, and the diseases such as the arterial sclerosis causing thus, thrombus, coronary heart disease, affect and have endangered middle-aged and old Health and Living quality day by day.In order to prevent the generation of this type of disease, people start more edible fish oil series products, due to existing various fish oil series products ubiquities on market: active ingredient is simple, functional component content is low, functional component proportioning is unreasonable, cause that product function is single, the shortcoming of DeGrain, be difficult to play desirable prophylactic effect.
(3) summary of the invention
The present invention is in order to make up the deficiencies in the prior art, a kind of deep-sea fish oil soft capsules that contains Co-Q10 is provided, main active ingredient is: deep sea fish oil [contain EPA(eicosapentaenoic acid), DHA(DHA)], Co-Q10, vitamin E, major auxiliary burden is water, glycerine and edible animal gelatin.
EPA in deep sea fish oil, DHA composition are a kind of special unrighted acids, and being is of value to the sanguimotor protection factor.EPA can assist to remove the cholesterol and the harden plaque that are attached on vascular wall, reduces Blood Cholesterol level, contributes to keep unobstructed blood to flow, and suppresses undesired blood aggegation, pre-preventing thrombosis generation, stops the generation of apoplexy or miocardial infarction.
Co-Q10 is that prevention of arterial sclerosis forms the most effective anti-oxidant composition, can resist oxidation effect of low-density lipoprotein in blood, reduce artery sclerosis and form, and be also prevention miocardial infarction and most important one defence line of cerebral thrombosis.Co-Q10 can not only be that cardiac muscle is produced energy, also can stablize cardiac pulses and heart conducting system, lowers the risk of suffering from rhythm abnormality or palpitaition problem.Once cardiac muscle can be produced more multipotency, just can bring into play more powerful pulsation ability.Blood more circulates, and blood vessel has more flexible elasticity, makes the heart naturally also can be more healthy.
Vitamin E can protect highly unsaturated fatty acid (EPA, DHA) not oxidized, extends shelf life of products.
The invention has the beneficial effects as follows, this fish oil soft capsule effectively combines ω-3 highly unsaturated fatty acid (EPA, DHA) and fat-soluble Co-Q10, between composition, further acts synergistically, and can prevent better cardiovascular and cerebrovascular disease.Co-Q10, for cardiac muscle cell provides more multipotency, strengthens cardiac function simultaneously, can rapidly, effectively improve cardiovascular and cerebrovascular disease symptom.
(4) detailed description of the invention
1, preparation content: by admixed together according to certain formula to raw material deep sea fish oil, Co-Q10, vitamin E, stir, the percentage by weight of content functional component net content is: EPA:32.4%, DHA:21.6%, Co-Q10: 9%, vitamin E: 1%.。
2, make capsule body material: taking edible gelatin, glycerine and pure water as utricule raw material, glycerine and pure water are proportionally injected in glue pot, and heating is stirred to 75 DEG C of left and right, then adds gelatin, continue to stir final vacuum deaeration in 20～30 minutes, make and obtain envelop materials.
3, the content preparing and capsule body are passed through to pelleting, moulding, wash ball, are dried, make finished product deep-sea fish oil soft capsules.
Claims (3)
1. a deep-sea fish oil soft capsules that contains Co-Q10, is characterized in that: the percentage by weight of capsule 's content is fish oil: 90%, Co-Q10: 9%, vitamin E: 1%.
2. a kind of deep-sea fish oil soft capsules that contains Co-Q10 according to claim 1, is characterized in that: in fish oil, the mass percent of functional component EPA is 36%, the mass percent of DHA is 24%.
3. a kind of deep-sea fish oil soft capsules that contains Co-Q10 according to claim 1, is characterized in that: the mass percent of capsule 's content functional component is EPA:32.4%, DHA:21.6%, Co-Q10: 9%, vitamin E: 1%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410260111.6A CN103989185A (en) | 2014-06-12 | 2014-06-12 | Deep sea fish oil soft capsule containing coenzyme Q |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410260111.6A CN103989185A (en) | 2014-06-12 | 2014-06-12 | Deep sea fish oil soft capsule containing coenzyme Q |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103989185A true CN103989185A (en) | 2014-08-20 |
Family
ID=51303725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410260111.6A Pending CN103989185A (en) | 2014-06-12 | 2014-06-12 | Deep sea fish oil soft capsule containing coenzyme Q |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103989185A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108851063A (en) * | 2018-08-03 | 2018-11-23 | 汤臣倍健股份有限公司 | A kind of Co-Q10 natural vitamin E soft capsule and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005000033A (en) * | 2003-06-10 | 2005-01-06 | Shinbijuumu:Kk | Food |
| CN1682714A (en) * | 2005-02-28 | 2005-10-19 | 重庆森尔维科技有限公司 | Composition for preventing cardiovascular system diseases |
| WO2012145369A1 (en) * | 2011-04-22 | 2012-10-26 | Faerstein Paul Joseph | Compositions and methods for nutritional supplementation |
| CN102754829A (en) * | 2012-07-03 | 2012-10-31 | 广东仙乐制药有限公司 | Healthcare composition containing coenzyme Q10, capsule preparation and preparation method |
-
2014
- 2014-06-12 CN CN201410260111.6A patent/CN103989185A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005000033A (en) * | 2003-06-10 | 2005-01-06 | Shinbijuumu:Kk | Food |
| CN1682714A (en) * | 2005-02-28 | 2005-10-19 | 重庆森尔维科技有限公司 | Composition for preventing cardiovascular system diseases |
| WO2012145369A1 (en) * | 2011-04-22 | 2012-10-26 | Faerstein Paul Joseph | Compositions and methods for nutritional supplementation |
| CN102754829A (en) * | 2012-07-03 | 2012-10-31 | 广东仙乐制药有限公司 | Healthcare composition containing coenzyme Q10, capsule preparation and preparation method |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108851063A (en) * | 2018-08-03 | 2018-11-23 | 汤臣倍健股份有限公司 | A kind of Co-Q10 natural vitamin E soft capsule and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104082751A (en) | Deep sea fish oil soft capsule containing astaxanthin | |
| Asif | Chemical characteristics and nutritional potentials of unsaturated fatty acids | |
| CN104351790B (en) | Health food | |
| CN104055123A (en) | Gamma-linolenic acid containing deep sea fish oil soft capsule | |
| CN103989179A (en) | Deep sea fish oil soft capsule containing ginkgo leaf extract | |
| CN104000208A (en) | Soft deep sea fish oil capsule containing squalene | |
| CN103989181A (en) | Walnut oil-containing fish oil soft capsule | |
| CN101961352A (en) | Self-emulsified fish oil soft capsules without fishy smell | |
| CN104543274B (en) | A kind of soft sweets containing DHA | |
| CN104106793A (en) | Food and preparation method thereof | |
| Saidaiah et al. | A comprehensive review of Omega-3 fatty acids: Sources, industrial applications, and health benefits | |
| CN108651635A (en) | Has effects that the nutrition-balanced health-care edible oil of brain boosting and supplementing | |
| CN103989185A (en) | Deep sea fish oil soft capsule containing coenzyme Q | |
| CN103989180B (en) | Deep-sea fish oil soft capsules containing Salvia root P.E | |
| CN104127857A (en) | Fish oil soft capsule and preparation method thereof | |
| CN101194913A (en) | Natural seal oil compression biological preparation for treating hyperlipidemia and technique of preparing the same | |
| CN103989176B (en) | Deep-sea fish oil soft capsules containing kudzu root extract | |
| CN103766909A (en) | Novel food rich in omega-3 compounded food supplement | |
| CN103989175A (en) | Deep sea fish oil soft capsule containing apocynum venetum extract | |
| CN104082741A (en) | Soft seal oil capsule containing astaxanthin | |
| CN104172151A (en) | Seal oil soft capsules containing coenzyme Q10 | |
| CN104055117A (en) | Seal oil soft capsule containing arachidonic acid | |
| CN103989178A (en) | Deep sea fish oil soft capsule containing ginkgo leaf oil | |
| CN104187727A (en) | Seal oil soft capsule containing salvia miltiorrhiza extract | |
| CN104187676A (en) | Seal oil soft capsule containing kudzuvine root extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140820 |